![](/img/cover-not-exists.png)
O.9 First-in-human phase I study to assess safety, tolerability and dose for intrathecal injection of ISIS-SMNRx in SMA patients
Swoboda, K., Chiriboga, C., Darras, B., Iannaccone, S., Montes, J., Rausch, N., Parad, R., Johnson, S., Vivo, D. De, Norris, D., Alexander, K., Bennet, F.C., Bishop, K.Volume:
23
Language:
english
Journal:
Neuromuscular Disorders
DOI:
10.1016/j.nmd.2013.06.559
Date:
October, 2013
File:
PDF, 57 KB
english, 2013